According to the Securities Act of 1933, every company has to register its offering with the SEC in order to sell its shares. There are situations where exemptions allow the companies to sell their shares without an SEC registration. There are two exemptions — Reg D 506b and Reg D 506c.
Reg D 506b and Reg D 506c
Reg D provides three exemptions from the registration, Rule 504, Rule 505 and Rule 506. For purposes of online equity crowd investing, Rule 506 is most significant, and it splits into two different variations, 506b, and 506c. In each case, only accredited…
A highly accurate, portable, and reusable COVID self-test for smartphones
Purdue University and IdentifySensors Biologics have partnered to create Check4-COVID™: a highly accurate, over-the-counter device intended to detect COVID-19 RNA in minutes in early and asymptomatic infections.
The device uses newly developed nanosensors, saliva, and a smartphone to pinpoint infections in minutes that current tests and home tests miss. It is intended to be sold at pharmacies at $80 for the device and $21 for each test. The system will also detect the new variants of COVID-19. This over-the-counter device is intended to be used entirely at…
Wednesday, Jan 27th, 11:00 am — 12:15 pm (PST) | 2:00 pm to 3:15 pm (EST)
Sign up for the webinar for free, it only takes 10 seconds.
In this webinar, we will be discussing how to Use Reg A+ for a SPAC Up To $75M To The NASDAQ
We will discuss the following aspects and uses of Reg A+ for your SPAC;
- Advantages of using Reg A+ for your SPAC IPO
- The methods that must be used
- Choice of the method to IPO your SPAC to the NASDAQ
- Underwriter involvement
Biologx Proprietary Technology Rapidly Produces Insulin, at 70% Less Than Current Prices to the Patient
Biologx has devised unique processes for the production of Insulin that enable them to make high-quality insulin in the US at lower cost. Attractive Investment that can save lives.
- 35–40% higher product yield compared to competitors
- 5 times faster production time
- 3 times fewer production steps
- 75% less overhead expenses
Biologx has filed with the SEC to qualify their Reg A+. Make a reservation now to lock in the initial share price.
Reserve now — Minimum reservation $300
Wednesday, Dec 16th, 11:00 am — 12:15 pm (PDT) | 2:00 pm to 3:15 pm (EST)
Sign up for the webinar for free, it only takes 10 seconds
We will discuss the following aspects and uses of Reg A+
- Advantages of using Reg A+ for your IPO
- Choice of method to IPO to the NASDAQ
- Underwriter involvement
- Marketing and costs
- Liquidity for Insiders and early investors
- OTC IPO how and why to take this approach
- What it takes to perform post IPO
- Raising $75 mill for divisions…
The SEC has decided to increase by 50% the maximum offering amount under Tier 2 of Reg A+ from $50 million to $75 million per year, effective 60 days after publication in the Federal Register.
Note that companies that already have Qualified their Reg A+ will be allowed to file a Post Qualification Amendment with the SEC to increase the amount of capital sought in their Reg A+ after the change is effective.
The SEC announcement has caused some confusion by referring to "secondary offerings" being increased from $15 mill to $22.5 mill, because the term "Secondary Offerings" is often…
Building compact and portable test devices to detect COVID-19.
Edoceo is raising $20M with their Reg A+ offering to fast-track development of a testing platform Called V-Detect, their SARS-CoV-2 Virus Test for use in Doctor’s offices, Clinics, and Airports.
- Results in under 30 minutes
- Accurate method that greatly reduces false positive and negative results
- COVID-19 test based on RNA amplification
Anyone can invest — Minimum Investment $580
Rod Turner will discuss the characteristics to look for in companies raising capital through online crowd-investing;
- The advantages and risks of investing in early-stage private companies
- The types of online offerings, including debt, equity and convertibles
- The differences between Reg CF, Reg D and Reg A+ from an investor’s perspective
- The different types of companies that tend to have success long term
- The types of companies that may have difficulties long term
- Positive characteristics to look for
- Signs of high-risk companies
- How to regulate your own investment activity
- Investor Liquidity